[1]
Sadanandam Akari and Sarumathy S, “PHARMACEUTICAL CARE IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND PHARMACO-ECONOMICAL BURDEN ON DIABETES PATIENT, COVID RECOVERED DIABETIC PATIENTS WITH CO-MORBID CONDITION”., J Popl Ther Clin Pharmacol, vol. 29, no. 04, pp. 4457–4476, Nov. 2022, doi: 10.53555/w4xxma59.